#obesity #diabetes #MASH Eli Lilly and Companys three strategies to expand obesity market(TAM) The global obesity drug market is forecast to grow from US$11.6bn in 2022, to US$68.9bn in 2025, and to US$150.6bn in 2030
Combine any form of L-Carnitine with: A mild calorie deficit 3045 minutes of daily exercise Adequate sleep (78 hours) Enough protein intake (especially important for Indians on high-carb diets) Do all of the above, and L-Carnitine in any format will help you see real, sustainable fat loss results
It is not intended to be used to diagnose, treat, cure or prevent disease
GLP-1 receptor agonists work with your biology instead, targeting the specific hormonal pathways that regulate appetite, satiety, and metabolic function
However, Wegovy has been available for longer than many newer medications, making it more accessible and cost-effective over time